When Dr. Pestell was our CMO. (2018-2019)... He was being interviewed and in the process of that interview he revealed that We are the owners of a Technology called NANOSTRING...a prostate cancer prognostic test...We acquired from Prostagene.

What have We done with this...???...Ohm,....anyone.